Piroxicam

Piroxicam, piroxicam, 36322-90-4, Feldene, Piroxicamum, Pyroxycam, Roxicam, BAXO, Piroftal, CP-16171, Larapam, CP 16171, 2H-1,2-Benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-2-pyridinyl-, 1,1-dioxide, CHF 1251, DTXSID5021170, 13T4O6VMAM, NSC-666076, CHEBI:8249, CP-16,171, 4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid, NSC666076, DTXCID401170, 4-hydroxy-2-methyl-1,1-dioxo-N-pyridin-2-yl-1lambda6,2-benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-(pyridin-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide, CP16171, Flamatrol, Kentene, Feldene p, 4-hydroxy-2-methyl-1,1-dioxo-N-(pyridin-2-yl)-2H-1$l^(6),2-benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-1,1-dioxo-N-(pyridin-2-yl)-2H-1$l^{6},2-benzothiazine-3-carboxamide, Piroflam 10, Piroflam 20, Feldene 20, Pirozip 10, Pirozip 20, RefChem:6147, M01AC01, M02AA07, S01BC06, 4-Hydroxy-2-methyl-N-2-pyridinyl-2H-1,2-benzothiazine-3-carboximide-1,1-dioxide, 252-974-3, Brexidol, 4-Hydroxy-2-methyl-N-(pyridin-2-yl)-2H-benzo[e][1,2]thiazine-3-carboxamide 1,1-dioxide, Artroxicam, C15H13N3O4S, NSC 666076, 4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide, MFCD00057317, 4-Hydroxy-2-methyl-3-(pyrid-2-yl-carbamoyl)-2H-1,2-benzothiazine 1,1-dioxide, 4-Hydroxy-2-methyl-N-2-pyridyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide, MLS000069644, 1044566-76-8, 4-Hydroxy-2-methyl-N-2-pyridinyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide, 2H-1,2-Benzothiazine-3-carboxamide,4-hydroxy-2-methyl-N-2-pyridinyl-, 1,1-dioxide, 4-hydroxy-2-methyl-N-pyridin-2-yl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide, NCGC00015823-02, Bruxicam, Caliment, Flogobene, Geldene, Improntal, Piroflex, Reudene, Roxiden, Sasulen, SMR000035997, Solocalm, Erazon, Pirkam, Riacen, Zunden, Roxam, CAS-36322-90-4, Piroxicamum [INN-Latin], (3Z)-3-{hydroxy[(pyridin-2-yl)amino]methylidene}-2-methyl-3,4-dihydro-2H-1lambda6,2-benzothiazine-1,1,4-trione, Rosiden, Felden, Feldene Fast, Feldene Gel, (4-hydroxy-2-methyl-1,1-dioxobenzo[e]1,2-thiazin-3-yl)-N-(2-pyridyl)carboxamid e, 4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-Dioxide, Feldene (TN), Piroxicam (Feldene), CCRIS 3719, SR-01000000199, EINECS 252-974-3, AK1015, UNII-13T4O6VMAM, BRN 0627692, Flamatrol, , Improntal, , Cycladol, , Piroflam, , Larapam, , Pirozip, , Reudene, , Brexin, , Piroxicam CRS, Fasax, , Pirox, , Prestwick_573, 4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid [German], Piroxicam (Standard), Piroxicam [USAN:USP:INN:BAN:JAN], piroxicam:malonic acid, Spectrum_001115, Tocris-0960, Opera_ID_442, PIROXICAM [INN], PIROXICAM [JAN], Piroxicam: Form Alpha1, Piroxicam: Form Alpha2, PIROXICAM [MI], PIROXICAM [USAN], Prestwick0_000211, Prestwick1_000211, Prestwick2_000211, Prestwick3_000211, Spectrum2_001287, Spectrum3_000780, Spectrum4_000968, Spectrum5_001445, Lopac-P-5654, PIROXICAM [VANDF], PIROXICAM ANHYDROUS, CHEMBL527, Epitope ID:613453, PIROXICAM [MART.], P 5654, PIROXICAM [USP-RS], PIROXICAM [WHO-DD], BIDD:PXR0154, Lopac0_000900, Oprea1_714707, SCHEMBL13462, SCHEMBL21350, BSPBio_000221, BSPBio_001030, BSPBio_002460, KBioGR_000370, KBioGR_001315, KBioSS_000370, KBioSS_001595, MLS000038002, MLS001148207, MLS001304054, MLS004774122, DivK1c_000369, SPECTRUM1500491, SPBio_001293, SPBio_002142, Piroxicam (JP18/USP/INN), BPBio1_000245, GTPL7273, orb1310318, Piroxicam, >=98% (TLC), SCHEMBL3703617, PIROXICAM [ORANGE BOOK], Piroxicam for system suitability, CHEMBL1518938, PIROXICAM [EP MONOGRAPH], SCHEMBL29352427, SCHEMBL29396075, BCBcMAP01_000176, BDBM85245, HMS501C11, HY-B0253R, KBio1_000369, KBio2_000370, KBio2_001595, KBio2_002938, KBio2_004163, KBio2_005506, KBio2_006731, KBio3_000719, KBio3_000720, KBio3_001680, MSK7162, PIROXICAM [USP MONOGRAPH], NINDS_000369, Piroxicam 1.0 mg/ml in Methanol, Bio1_000363, Bio1_000852, Bio1_001341, Bio2_000355, Bio2_000835, GLXC-26155, GLXC-26156, HMS1362D11, HMS1568L03, HMS1792D11, HMS1920H22, HMS1990D11, HMS2089B06, HMS2092A05, HMS2095L03, HMS2231G03, HMS3262D22, HMS3267I03, HMS3369B07, HMS3403D11, HMS3414H17, HMS3429L03, HMS3655C04, HMS3678H15, HMS3712L03, HMS3884C08, HMS5079F16, Pharmakon1600-01500491, HY-B0253, NSC_4856, Tox21_110231, Tox21_200151, Tox21_500900, CCG-36403, EBC-11158, EBC-26614, MSK7162-100A, NSC757284, Piroxicam for system suitability CRS, s1713, STK177288, AKOS000714958, AKOS025312555, AKOS026749939, MSK7162-1000A, Tox21_110231_1, DB00554, FP27085, KS-5322, LP00900, NSC-757284, SDCCGSBI-0050875.P005, (4-Hydroxy-2-methyl-1,1-dioxobenzo[e]1,2-thiazin-3-yl)-N-(2-pyridyl)carboxamide, 4-hydroxy-2-methyl-N-2-pyridinyl-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide, IDI1_000369, IDI1_002110, NCGC00015823-01, NCGC00015823-03, NCGC00015823-04, NCGC00015823-05, NCGC00015823-06, NCGC00015823-07, NCGC00015823-08, NCGC00015823-09, NCGC00015823-10, NCGC00015823-11, NCGC00015823-12, NCGC00015823-13, NCGC00015823-14, NCGC00015823-15, NCGC00015823-17, NCGC00015823-18, NCGC00015823-20, NCGC00015823-29, NCGC00021244-03, NCGC00021244-05, NCGC00021244-06, NCGC00021244-07, NCGC00021244-08, NCGC00021244-09, NCGC00188982-01, NCGC00257705-01, NCGC00261585-01, (Z)-3-(hydroxy(pyridin-2-ylamino)methylene)-2-methyl-2H-benzo[e][1,2]thiazin-4(3H)-one 1,1-dioxide, AC-24190, NCI60_022912, ST069379, SBI-0050875.P004, CAS_36322-90-4, Piroxicam, meets USP testing specifications, EU-0100900, NS00015466, P1905, SW219862-1, EN300-70724, Piroxicam Solution in Acetonitrile, 100ug/mL, C01608, D00127, D70554, Piroxicam Solution in Acetonitrile, 1000ug/mL, AB00052074-21, AB00052074-22, AB00052074_23, AB00052074_24, F340495, Q408676, SR-01000000199-3, SR-01000000199-5, SR-01000000199-9, SR-01000000199-12, F0001-2399, Piroxicam, British Pharmacopoeia (BP) Reference Standard, Z1137167677, Piroxicam, European Pharmacopoeia (EP) Reference Standard, Piroxicam, United States Pharmacopeia (USP) Reference Standard, Piroxicam, Pharmaceutical Secondary Standard, Certified Reference Material, 4-hydroxy-2-methyl-1,1-dioxo-N-(2-pyridyl)-1$l^{6},2-benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-1,1-dioxo-N-(2-pyridyl)-1lambda6,2-benzothiazine-3-carboxamide, 4-Hydroxy-2-methyl-3-(2-pyridylcarbamoyl)-2H-1,2-benzothiazine 1,1-Dioxide, 4-Hydroxy-2-methyl-N-(pyridin-2-yl)-2H-benzo[e][1,2]thiazine-3-carboxamide1,1-dioxide, 4-Hydroxy-2-methyl-N-2-pyridinyl-2H-1,2-benzothiazine-3-carboxamide1,1-dioxide, N-(2-pyridyl)-4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide, 3-(Hydroxy[(pyridin-2-yl)amino]methylidene)-2-methyl-3,4-dihydro-2h-1lambda(6),2-benzothiazine-1,1,4-trione, 3-{hydroxy[(pyridin-2-yl)amino]methylidene}-2-methyl-3,4-dihydro-2H-1$l^{6},2-benzothiazine-1,1,4-trione, 3-{hydroxy[(pyridin-2-yl)amino]methylidene}-2-methyl-3,4-dihydro-2H-1lambda6,2-benzothiazine-1,1,4-trione, 4-Hydroxy-2-methyl-1,1-dioxo-N-(pyridin-2-yl)-1,2-dihydro-1lambda~6~,2-benzothiazine-3-carboxamide, 4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazine -3-carboxamide-1,1-dioxide malonic acid